Successful innovation: A time for change?
Innovation plays an important role in the advancement of nuclear cardiology, meeting the need for reduced exposure to radiation, and maintaining and improving image quality. As we innovate, it is important to understand the impact of these improvements on the clinical and research knowledge base that has made nuclear cardiology such a powerful clinical tool. The need for comparative studies insuring stability in the clinical applicability of our current guidelines and use of the prognostic power of radionuclide myocardial perfusion imaging in clinical practice is essential for new and innovative techniques. The existing data demonstrating the significant differences that can occur with the innovative techniques is explored. The need for tools to insure comparable data is available as we begin to utilize registries to inform our clinical practice and research will be an important part of the future of nuclear cardiology.
KeywordsSPECT image processing image reconstruction
- 8.Heller G, Mann A, Hendel R. Nuclear cardiology: Technical applications: Technical applications. New York: McGraw-Hill; 2008.Google Scholar
- 15.Shaw LJ, Berman DS, Maron DJ, Mancini GJ, Hayes SW, Hartigan PM, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: Results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation 2008;117:1283-91. doi: 10.1161/CIRCULATIONAHA.107.743963.CrossRefPubMedGoogle Scholar
- 17.Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107:2900-7. doi: 10.1161/01.CIR.0000072790.23090.41.CrossRefPubMedGoogle Scholar
- 18.Hachamovitch R, Rozanski A, Hayes SW, Thomson LE, Germano G, Friedman JD, et al. Predicting therapeutic benefit from myocardial revascularization procedures: Are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? J Nucl Cardiol 2006;13:768-78. doi: 10.1016/j.nuclcard.2006.08.017.CrossRefPubMedGoogle Scholar
- 19.Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979;59:421. doi: 10.1161/01.cir.59.3.421.CrossRefPubMedGoogle Scholar
- 26.DePuey EG, Bommireddipalli S, Clark J, Thompson L, Srour Y. Wide beam reconstruction “quarter-time” gated myocardial perfusion SPECT functional imaging: A comparison to “‘full-time’” ordered subset expectation maximum. J Nucl Cardiol 2009;16:736. doi: 10.1007/s12350-009-9108-7.CrossRefPubMedGoogle Scholar
- 28.Badano LP, Cucchini U, Muraru D, Al Nono O, Sarais C, Iliceto S. Use of three-dimensional speckle tracking to assess left ventricular myocardial mechanics: Inter-vendor consistency and reproducibility of strain measurements. Eur Heart J Cardiovasc Imaging 2012;14:285-93. doi: 10.1093/ehjci/jes184.CrossRefPubMedGoogle Scholar